NCT05745389 CorEvitas Alopecia Areata (AA) Safety and Effectiveness Registry
| NCT ID | NCT05745389 |
| Status | Recruiting |
| Phase | — |
| Sponsor | CorEvitas |
| Condition | Alopecia Areata |
| Study Type | OBSERVATIONAL |
| Enrollment | 5,000 participants |
| Start Date | 2022-10-25 |
| Primary Completion | 2099-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 5,000 participants in total. It began in 2022-10-25 with a primary completion date of 2099-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Prospective, observational cohort study for subjects with AA under the care of a dermatology provider. Approximately 5,000 subjects and 100 clinical sites in North America will be recruited to participate with no defined upper limit for either target.
Eligibility Criteria
Inclusion Criteria: * A subject must meet all the following criteria to participate in the registry: 1. Has been diagnosed with alopecia areata by a dermatologist or a qualified dermatology practitioner. 2. Is at least 18 years of age or older. 3. Is willing to provide Personal Information. 4. Is prescribed or starting an Enrollment Eligible Medication at the time of enrollment. Exclusion Criteria: * Any of the following would exclude the subject from participating in the registry: 1. Is participating or planning to participate in a double-blind randomized trial for an AA drug. Note: Concurrent participation in another observational registry or open-label Phase 3b/4 trial is allowed.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05745389 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Alopecia Areata. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05745389 currently recruiting?
Yes, NCT05745389 is actively recruiting participants. Contact the research team at corevitasregistrytrials@corevitas.com for enrollment information.
Where is the NCT05745389 trial being conducted?
This trial is being conducted at Waltham, United States.
Who is sponsoring the NCT05745389 clinical trial?
NCT05745389 is sponsored by CorEvitas. The trial plans to enroll 5,000 participants.